Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FTKQJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,786
Award facts
- Contract value 100% obligated
- $3,785.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,785.80 by the Defense Logistics Agency on August 29, 2025, for the supply of NUCALA 100 mg/mL auto-injector medication. The contract carries an ultimate completion date of September 2, 2025, and was issued without set-aside designation. This delivery order will be performed at the vendor's location in Park Ridge, Illinois, and represents a direct pharmaceutical supply transaction supporting Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military health facilities nationwide. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and specialty medications to government healthcare systems. NUCALA, a biologic auto-injector medication for eosinophilic conditions, represents the type of specialized pharmaceutical product the vendor regularly supplies through this comprehensive supply contract framework.
Quick answers
Who was awarded contract SPE2DB25FTKQJ?
SPE2DB25FTKQJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FTKQJ worth?
The government has obligated $3,786 on SPE2DB25FTKQJ.
Is contract SPE2DB25FTKQJ an order under another contract?
Yes. SPE2DB25FTKQJ is a delivery order under SPE2DB22D9112, an indefinite delivery contract.
Was contract SPE2DB25FTKQJ competed?
The extent of competition for SPE2DB25FTKQJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award